Some patients with amyotrophic lateral sclerosis (ALS) or frontotemporal lobar dementia (FTLD) exhibit the nearly complete absence of Tau protein in the cortex despite normal Tau mRNA expression. The gene discussed is MAPT; the disease is amyotrophic lateral sclerosis.